Cargando…
Changes of allergic inflammation and immunological parameters after Alt a 1 and A. alternata immunotherapy in mice
BACKGROUND: The efficacy of allergen-specific subcutaneousimmunotherapy (SCIT) with Alt a 1 of the fungus A. alternata is still unknown. Yet, few studies compare the therapeutic effects and immunological mechanisms of Alt a 1 and A. alternata extracts. We aim to explore and compare the changes in al...
Autores principales: | Liu, Juan, Li, Junda, Yin, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457585/ https://www.ncbi.nlm.nih.gov/pubmed/37638361 http://dx.doi.org/10.1016/j.waojou.2023.100807 |
Ejemplares similares
-
Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
por: Zeng, Yinhui, et al.
Publicado: (2023) -
Changes in the Sensitization Pattern to Alternaria alternata Allergens in Patients Treated with Alt a 1 Immunotherapy
por: Rodríguez, David, et al.
Publicado: (2021) -
Subcutaneous Immunotherapy (SCIT) with the New Polymerized Molecular Allergoid Alt a1: A Pilot Study in Children with Allergic Rhinitis Sensitized to Alternaria Alternata
por: Brindisi, Giulia, et al.
Publicado: (2023) -
Immunotherapy With Recombinant Alt a 1 Suppresses Allergic Asthma and Influences T Follicular Cells and Regulatory B Cells in Mice
por: Liu, Juan, et al.
Publicado: (2021) -
Aeroallergen immunotherapy associated with reduced risk of severe COVID-19 in 1095 allergic patients
por: Larenas-Linnemann, Désirée, et al.
Publicado: (2023)